A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy

Kidney International

Volumn 56, Issue 4, 1999, Pages 1317-1323

  Ando, Minoru ^a   Sasaki, Jun ^b   Hua, Han ^c   Matsunaga, Akira ^d   Uchida, Keiko ^a   Jou, Kensuke ^b   Oikawa, Shinichi ^c   Saito, Takao ^d   Nihei, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c Jikeikai Medical School   (Japan)

^d TOHOKU UNIVERSITY   (Japan)

Author keywords

Amino acid deletion; Apollpoprotein E1; Atherosclerosis; Gene mutation; Proteinuria

Indexed keywords

AMINO ACID; APOLIPOPROTEIN E;

ADULT; ATHEROGENESIS; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; GENE DELETION; GENE MUTATION; GENOTYPE; GLOMERULOPATHY; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; ISOELECTRIC FOCUSING; KIDNEY BIOPSY; LIPOPROTEIN BLOOD LEVEL; MALE; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT;

EID: 0032873305     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00677.x     Document Type: Conference Paper

References (17)

1. SAITO T, SATO H, KUDO K, OIKAWA S, SIIIBATA T, HARA Y, YosiuNAGA K, SAHAGUCIII H: Lipoprotein glomerulopalhy: Glomerular lipoprotein thrombi in a patient with hyperlipoprotcinemia. Am J Kidney Dis 13:148-153, 1989
2. W ATANABE O, OZAKI I, YOSIIIDA F, FUKATSU A, ITOU Y, MATSUO S, SAKAMOTO N: A case of nephrotic syndrome with glomerular lipoprotein deposition with capillary ballooning and mesangiolysis. Nephron 51:265-270, 1989
3. OIKAWA S, SUZUKI N, SAKUMA E, SAITO T, NAMAI K, KOTAKE H, FUJII Y, TOYOTA T: Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy. Am J Kidney Dis 18:553-558, 1991
4. OIKAWA S, MATSUNAGA A, SAITO T, SATO H, SEKI T, HOSIII K, HAYASAKA K, KOTAKE H, MIDORIKAWA H, SEKIKAWA A, HARA S, ABE K, TOYOTA T, JINGAMI H, NAKAMURA H, SASAKI J: Apolipoprotein E Sendai (arginine 145proline): A new variant associated with lipoprotein glomerulopathy. J Am Soc Ncplirol 8:820-823, 1997
5. MORIYAMA K, SASAKI J, MATSUNAGA A, ARAKAWA F, TAKADA Y, ARAKI K, KANEKO S, ARAKAWA K: Apolipoprotein El Lys-146-Glu with type III hyperlipoproteinemia. Biocliiin Biophys Ada 1128:58-64, 1992
6. HIXSON JE, VERNIER DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipitl Res 31:545-548, 1990
7. EMI M, Wu LL, ROBERTSON A, MYERS RL, HEGFELE RA, WILLIAMS RR, WHITE R, LANLOUEL TM: Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 3:373-379, 1988
8. MORIYAMA K, SASAKI J, TAKADA Y, ARAKAWA F, MATSUNAGA A, ITO Y, ARAKAWA K: Characterization of a novel variant of apolipoprotein E. E2 Fukuoka (Arg-224Gln) in a hyperlipidemic patient with xanthomatosis. Bioclum Biopliys Actn 1301:185-190, 1996
9. DAS HK, McPHERSON J, BRUNS GA, KARATHANASIS SK, BRESLOW JL: Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Clicin 260:6240-6247, 1985
10. MAULEY RW: Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240:622-630, 1988
11. DE KNUFF P, VAN DEN MAAGDENBERG AM, FRANTS RR, HAVEKES LM: Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum Mutai 4:178-194,1994
12. WEISGRABER KH: Apolipoprotein E: Structure-function relationships. Adv Protein Cliem 45:249-302, 1994
13. LALAZARA WEISGRABER KH, RALL SC JR. GILADI H, INNERARITY TL, LEVANON AZ, BOYLES JK, AMI? B, GORECKI M, MAULEY RW, VOGEL T: Site-specific mutagenesis of human apolipoprotein E: Receptor binding activity of variants with single amino acid substitutions. J Biol Clicin 263:3542-3545, 19SS
14. SAITO T, OIKAWA S, SATO H, CIIIBA J: Lipoprotein glomerulopathy and its pathogenesis. Contrib Nephrol 120:30-38, 1997
15. YANG A, Nc Y, TARNG D, CIIEN J, SIIIAO M, KAO J: Association of apolipoprotein E polymorphism with lipoprotein glomerulopathy: Report of 2 cases with a new genotype and comparison of the relative frequencies of apolipoprotein E isoforms in lipoprotein glomerulopathy and in the general population. Nephron 78:266270, 1998
16. ELSIIOURBAGY NA, LIAO WS, MAULEY RW, TAYLOR JM: Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Nail Acad Sei USA 82:203-207, 1985
17. SAITO T, SATO H, OIKAWA S: Lipoprotein glomerulopathy: A new aspect of lipid induced glomerular injury. Nephrology 1:17-24,1995